DNA Genotek Reaches Exclusive Distribution Agreement with Abyntek Biopharma S.L. in Spain

Share Article

DNA Genotek signs exclisive distribution agreement with Abyntek Biopharma in Spain.

dna collection kit, dna saliva

Oragene/saliva DNA collection kit

“The addition of DNA Genotek’s world-class Oragene•DNA products to our lineup makes it easier for Abyntek to provide our customers with reliable and proven methods for DNA collection”, said Ainara Hernando, general manager, Abyntek Biopharma S.L.

DNA Genotek Inc.,a leading provider of products for biological sample collection, stabilization and preparation, announced today that it has signed a distribution agreement permitting Abyntek Biopharma S.L., part of Progenika Group, to exclusively distribute DNA Genotek’s Oragene®•DNA family of products in Spain. Abyntek Biopharma is one of Spain’s leading distributors of biological products.

Abyntek will offer DNA Genotek’s complete line of Oragene•DNA collection kits for the collection, stabilization, transportation and preparation of DNA from saliva on an exclusive basis for customers in Spain. Oragene•DNA enables easy, reliable and cost effective collection of samples from large numbers of individuals while providing high quality DNA. Abyntek is an integral part of Progenika Biopharma S.A., a pioneer in the field of Personalized Medicine.

“The addition of DNA Genotek’s world-class Oragene•DNA products to our lineup makes it easier for Abyntek to provide our customers with reliable and proven methods for DNA collection,” said Ainara Hernando, general manager, Abyntek Biopharma S.L. “We’re committed to offering products that will provide the best opportunities for success for our customers' research and clinical needs, and we believe DNA Genotek’s Oragene•DNA product will perfectly complement our offerings and facilitate personalized medicine applications for our customers.”

“This agreement strengthens DNA Genotek’s ability to support customers on a worldwide basis, complementing our overall focus on customer service,” said Brian Smith, vice president, sales, DNA Genotek Inc. “We see growing demand for our products for research, clinical applications, companion diagnostics and personalized medicine and this agreement provides an ideal addition to our ability to serve existing and new customers in this market.”

About Abyntek:
Abyntek Biopharma S.L. is a privately owned biotechnology company that centres its activity in developing, producing and commercializing antigens and antibodies. A strong investment in R+D constitutes one of the fundamental values on which the business strategy of Abyntek is based, mainly focused on the development of new technologies to produce monoclonal antibodies. Abyntek is part of Progenika Group, pioneers in Personalized Medicine.

About DNA Genotek:
DNA Genotek focuses on providing high-quality biological sample collection products. The company’s Oragene family of products provides the best way to collect and preserve large amounts of DNA or RNA from saliva. The company also offers a family of products for collecting DNA from animals and livestock. The reliability and ease-of-use of the company’s products have resulted in rapid adoption at top-tier health research institutions globally, including Harvard, Stanford, Cambridge, and Johns Hopkins. DNA Genotek markets its products worldwide and has established a global customer base in over 100 countries. For more information about DNA Genotek, visit http://www.dnagenotek.com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Shauna White
Visit website